AI Article Synopsis
- Recent progress has been made in managing advanced basal cell carcinoma, but comprehensive clinical guidelines are still lacking for the use of Hedgehog pathway inhibitors.
- There is a need to address the complexities of applying these treatments in real-world settings.
- Expert physicians were consulted to gather their insights and develop practical tools for better clinical management of patients with advanced basal cell carcinoma.
Article Abstract
Despite recent progress and the publishing of several clinical guidelines on the management of advanced basal cell carcinoma, there is still no comprehensive set of clinical guidelines addressing the complexity inherent to the use of Hedgehog pathway inhibitors in the treatment of advanced basal cell carcinoma in real-world clinical practice. To develop practical and valuable tools that help specialists improve the clinical management of these patients, we sought the opinion of expert physicians with extensive knowledge and experience in the treatment of advanced basal cell carcinoma.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616316 | PMC |
| http://dx.doi.org/10.3390/cancers13225706 | DOI Listing |
Publication Analysis
Top Keywords
advanced basal
16
basal cell
16
cell carcinoma
16
treatment advanced
12
hedgehog pathway
8
pathway inhibitors
8
clinical guidelines
8
basal
4
cell
4
carcinoma
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!